The rhesus rotavirus gene encoding VP4 is a major determinant in the pathogenesis of biliary atresia in newborn mice
pubmed.ncbi.nlm.nih.gov shows its articles on its own site.
Read the article on pubmed.ncbi.nlm.nih.gov ↗Article · Jun 2011 · 1 min read
In brief
In brief
This study identifies the rhesus rotavirus VP4 gene as the critical determinant for biliary atresia development in a neonatal mouse model. Using viral reassortants, researchers demonstrated that VP4 governs cholangiocyte tropism and replication, with gain-of-function experiments producing 88% mortality from biliary obstruction.
Written by the GCMD Library team from the article.
Statements in this article
Rhesus rotavirus induces biliary atresia in the murine model when administered perinatally, while other rotavirus strains such as TUCH do not.
The loss-of-function reassortant R(T(VP4)), in which TUCH gene 4 replaced the RRV equivalent, eliminated the ability of rhesus rotavirus to cause murine biliary atresia.
The gain-of-function reassortant T(R(VP4)), in which RRV gene 4 replaced the TUCH equivalent, resulted in murine biliary atresia with 88% mortality.
R(T(VP4)) binding and titers in cholangiocytes were significantly attenuated compared with those for rhesus rotavirus.
T(R(VP4)) binding and titers in cholangiocytes were significantly increased over those for TUCH.
Reassortants R(T(VP3)) and T(R(VP3)) induced an intermediate phenotype in the murine biliary atresia model.
Rhesus rotavirus gene segment 4 plays a significant role in governing tropism for the cholangiocyte and the ability to cause biliary atresia.